The company, helmed by BioNTech alums, is developing therapies aimed at dermatological, respiratory and gut-related ...

Here is how Auna S.A. (AUNA) and BioNTech SE Sponsored ADR (BNTX) have performed compared to their sector so far this year.

In a report released today, Terence Flynn from Morgan Stanley maintained a Hold rating on Organon (OGN – Research Report), with a price target ...

Leerink Partners analyst Daina Graybosch maintained a Buy rating on Nkarta (NKTX – Research Report) yesterday and set a price target of $7.00.

Investors might want to bet on BioNTech SE Sponsored ADR (BNTX), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which ...

These are the kinds of stocks long-term investors will often be interested in, since they must have excellent, resilient ...

BioNTech SE (“BioNTech”) confirmed the completion of its acquisition of biotechnology company Biotheus for an upfront payment ...

After a major increase in deaths from COVID-19 in December, Carver County Public Health Director Richard Scott says numbers are dropping as the new year continues. Half of the county’s death ...

Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...

Shares of vaccine companies fell on Tuesday after a Senate panel voted to advance Robert F. Kennedy Jr.'s nomination to lead ...

BioNTech's financial position is robust, with approximately $18 billion in cash following the Biotheus acquisition. According to InvestingPro data, the company maintains an impressive current ...